Your browser doesn't support javascript.
loading
Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.
Dultz, Georg; Graubard, Barry I; Martin, Paul; Welker, Martin-Walter; Vermehren, Johannes; Zeuzem, Stefan; McGlynn, Katherine A; Welzel, Tania M.
Affiliation
  • Dultz G; University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Graubard BI; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Martin P; Hepatology Division, University of Miami, Miami, FL, United States of America.
  • Welker MW; University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Vermehren J; University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Zeuzem S; University Hospital Frankfurt, Frankfurt am Main, Germany.
  • McGlynn KA; HREB, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Welzel TM; University Hospital Frankfurt, Frankfurt am Main, Germany.
PLoS One ; 12(10): e0186898, 2017.
Article in En | MEDLINE | ID: mdl-29088255
ABSTRACT
Chronic hepatitis C virus (HCV) infection is a leading cause for orthotopic liver transplantation (OLT) in the U.S. We investigated characteristics of HCV-infected patients registered for OLT, and explored factors associated with mortality. Data were obtained from the United Network for Organ Sharing and Organ Procurement and Transplantation network (UNOS/OPTN) registry. Analyses included 41,157 HCV-mono-infected patients ≥18 years of age listed for cadaveric OLT between February 2002 and June 2014. Characteristics associated with pre- and post-transplant survival and time trends over the study period were determined by logistic and Cox proportional hazard regression analyses and Poisson regressions. Most patients were white (69.1%) and male (70.8%). At waitlist registration, mean age was 54.6 years and mean MELD was 16. HCC was recorded in 26.9% of the records. A total of 51.2% of the patients received an OLT, 21.0% died or were too sick; 15.6% were delisted and 10.4% were still waiting. Factors associated with increased waitlist mortality were older age, female gender, blood type 0, diabetes, no HCC and transplant region (p<0.001). OLT recipient characteristics associated with increased risk for post OLT mortality were female gender, age, diabetes, race (p<0,0001), and allocation MELD (p = 0.005). Donor characteristics associated with waitlist mortality included age, ethnicity (p<0.0001) and diabetes (p<0.03). Waitlist registrations and OLTs for HCC significantly increased from 14.4% to 37.3% and 27.8% to 38.5%, respectively (p<0.0001). Pre- and post-transplant survival depended on a variety of patient-, donor-, and allocation- characteristics of which most remain relevant in the DAA-era. Still, intensified HCV screening strategies and timely and effective treatment of HCV are highly relevant to reduce the burden of HCV-related OLTs in the U.S.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue and Organ Procurement / Registries / Liver Transplantation / Hepatitis C, Chronic Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2017 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue and Organ Procurement / Registries / Liver Transplantation / Hepatitis C, Chronic Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2017 Document type: Article Affiliation country: Germany
...